112 related articles for article (PubMed ID: 25275081)
1. Increase of peripheral blood CD57+ T-cells in patients with oral squamous cell carcinoma.
Iida M; Takayama E; Naganawa K; Mitsudo K; Adachi M; Baba J; Fujimoto-Muto M; Motohashi M; Mizuno-Kamiya M; Kawaki H; Kioi M; Ichinose M; Sumitomo S; Muramatsu Y; Shikimori M; Tohnai I; Kondoh N
Anticancer Res; 2014 Oct; 34(10):5729-34. PubMed ID: 25275081
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
4. Increased activation and expansion of a CD57+ subset within peripheral CD8+ T lymphocytes in Mycobacterium tuberculosis-infected patients.
Fateminasab FD; Shahgasempour S; Mirsaeidi SM; Tabarsi P; Mansoori SD; Entezami Z
Arch Iran Med; 2006 Jan; 9(1):53-7. PubMed ID: 16649379
[TBL] [Abstract][Full Text] [Related]
5. Altered cytokine levels and increased CD4+CD57+ T cells in the peripheral blood of hepatitis C virus-related hepatocellular carcinoma patients.
Shiraki T; Takayama E; Magari H; Nakata T; Maekita T; Enomoto S; Mori Y; Shingaki N; Moribata K; Deguchi H; Ueda K; Inoue I; Mizuno-Kamiya M; Yashiro K; Iguchi M; Tamai H; Kameyama Y; Kato J; Kondoh N; Ichinose M
Oncol Rep; 2011 Jul; 26(1):201-8. PubMed ID: 21491089
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
7. Altered invariant natural killer T cell subsets and its functions in patients with oral squamous cell carcinoma.
Singh AK; Shukla NK; Das SN
Scand J Immunol; 2013 Nov; 78(5):468-77. PubMed ID: 23980793
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood lymphocyte subsets in urinary bladder carcinoma patients.
Gaafar T; Lotfy M; el Ridi R
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):511-7. PubMed ID: 1726772
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma.
Manchanda P; Sharma SC; Das SN
Oral Dis; 2006 Sep; 12(5):455-62. PubMed ID: 16910915
[TBL] [Abstract][Full Text] [Related]
10. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
11. Changes in peripheral blood lymphocyte phenotypes distribution in patients with oral cancer/oral leukoplakia in Taiwan.
Lee JJ; Lin CL; Chen TH; Kok SH; Chang MC; Jeng JH
Int J Oral Maxillofac Surg; 2010 Aug; 39(8):806-14. PubMed ID: 20605406
[TBL] [Abstract][Full Text] [Related]
12. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment.
Gasparoto TH; de Souza Malaspina TS; Benevides L; de Melo EJ; Costa MR; Damante JH; Ikoma MR; Garlet GP; Cavassani KA; da Silva JS; Campanelli AP
Cancer Immunol Immunother; 2010 Jun; 59(6):819-28. PubMed ID: 20012605
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of natural killer cell defense in oral squamous cell carcinoma.
Türkseven MR; Oygür T
Oral Oncol; 2010 May; 46(5):e34-7. PubMed ID: 20347380
[TBL] [Abstract][Full Text] [Related]
14. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O
J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177
[TBL] [Abstract][Full Text] [Related]
15. CD4+CD25hiCD127low regulatory T cells are increased in oral squamous cell carcinoma patients.
Lim KP; Chun NA; Ismail SM; Abraham MT; Yusoff MN; Zain RB; Ngeow WC; Ponniah S; Cheong SC
PLoS One; 2014; 9(8):e103975. PubMed ID: 25153698
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical research for T cell subsets infiltrating in squamous cell carcinoma of oral cavity by monoclonal antibody].
Lu DH
Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Jan; 27(1):34-6, 62. PubMed ID: 1499396
[TBL] [Abstract][Full Text] [Related]
17. [The numbers and distribution studies of natural killer cell, T cell subsets in peripheral blood and local infiltration in patients with squamous cell carcinoma of the oral cavity].
Pan L
Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Jul; 27(4):225-7. PubMed ID: 1303835
[No Abstract] [Full Text] [Related]
18. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of CD57, CD16, and TGF-β expression in oral squamous cell carcinoma.
Taghavi N; Bagheri S; Akbarzadeh A
J Oral Pathol Med; 2016 Jan; 45(1):58-62. PubMed ID: 25808210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]